Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer
Precancerous Esophagus Disease Eliminated in 98.4% of Patients Treated With HALO Ablation System
August 5th, 2008
BARRX Medical, Inc. announced that 98.4 percent of patients having a precancerous condition of their esophagus called Barrett's esophagus were free of the disease 2.5 years after non-surgical, endoscopic treatment with the HALO ablation system. The results were published this month in Gastrointestinal Endoscopy, a leading scientific publication for gastrointestinal physicians and researchers. Barrett's esophagus develops as a result of chronic gastroesophageal reflux disease (GERD) and afflicts more than 3.3 million people in the United States. In this clinical trial, eight U.S. centers enrolled 70 patients having intestinal metaplasia, which is the earliest stage of...
Source: Cancer Weekly (2008-08-05)
|
